A 57-year-old with T2D, CKD, and albuminuria (UACR 220 mg/g) is on ACE inhibitor. eGFR 48. Which combination is evidence-based for kidney and CV benef...

Question

A 57-year-old with T2D, CKD, and albuminuria (UACR 220 mg/g) is on ACE inhibitor. eGFR 48. Which combination is evidence-based for kidney and CV benefit?

Accepted Answer

ACE inhibitor + SGLT2 inhibitor

Answer

ACE inhibitor + DPP-4 inhibitor

Answer

ACE inhibitor + SU

Answer

ACE inhibitor only

Answer

DPP-4 inhibitor only

us-abfm MCQ (SBA): CKD-Combination Therapy

A 57-year-old with T2D, CKD, and albuminuria (UACR 220 mg/g) is on ACE inhibitor. eGFR 48. Which combination is evidence-based for kidney and CV benefit?